Table 8.
Mean and median survival as calculated from Kaplan-Meier survival curves. Only IBM which gives statistical significance as demonstrated by the univariate analysis in Table 7 is included in this table
| Biomarkers | 5-Year Overall Survival | |||||
|---|---|---|---|---|---|---|
| Mean | 95% CI | Difference | Median | 95% CI | Difference | |
| Solid Composition | ||||||
| RDC | ||||||
| SD | 5.20 | 4.27–2.57 | 2.04 | 4.43 | 2.93–5.48 | 1.17 |
| NSD | 3.16 | 2.57–3.74 | 3.26 | 2.49–3.90 | ||
| LoFAR | ||||||
| SD | 5.50 | 4.46–6.61 | 2.23 | 5.20 | 3.11–5.24 | 2.00 |
| NSD | 3.27 | 2.75–3.79 | 3.20 | 2.71–3.84 | ||
| Solidity | ||||||
| SD | 4.96 | 4.08–5.85 | 1.64 | 3.90 | 2.85–5.48 | 0.58 |
| NSD | 3.32 | 2.68–3.96 | 3.32 | 3.15–3.84 | ||
| Lucent Composition | ||||||
| RLC | ||||||
| SD | 5.20 | 4.27–2.57 | 2.04 | 4.43 | 2.93–5.48 | 1.17 |
| NSD | 3.16 | 2.57–3.74 | 3.26 | 2.49–3.90 | ||
| ATR | ||||||
| SD | 5.05 | 4.11–5.99 | 1.69 | 3.78 | 2.76–5.48 | 0.46 |
| NSD | 3.36 | 2.82–3.90 | 3.32 | 3.15–3.90 | ||
| LoCAR | ||||||
| SD | 5.17 | 4.24–6.11 | 2.03 | 3.99 | 3.32–5.48 | 0.83 |
| NSD | 3.14 | 2.59–3.69 | 3.16 | 2.49–3.84 | ||
Data are presented in years